Posts Tagged: Alzheimer’s Disease


USF files patent suit over sale of Alzheimer’s research mice

On Tuesday, March 21st, a pre-trial hearing will take place in a case involving patent infringement claims targeting the sale of mice having mutated genes which make …
By Steve Brachmann
4 years ago 0

Senate passes 21st Century Cures Act, President Obama expected to quickly sign bill into law

Earlier today, by a vote of 94 to 5, the United States Senate overwhelmingly passed the 21st Century Cures Act. Having passed in the House, the Cures Act now …
By Gene Quinn
4 years ago 6

Putting the pieces together on how to cure Alzheimer’s

The most common form of dementia is Alzheimer’s disease, a progressive disorder of the human brain which over time reduces a person’s cognitive abilities to …
By Steve Brachmann
5 years ago 1

Merck, Pfizer and Eli Lilly patenting to stay ahead of patent cliff

The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here …
By Steve Brachmann
6 years ago 0

The University of California patents treatments for cancer and Alzheimer’s disease

The University of California maintains a portfolio of 11,556 active patent grants. Patented technologies which are currently available for licensing through UC include laser scanners for eye tracking, …
By Steve Brachmann
6 years ago 0

Merck Patents Drugs for Metabolic Disorders & Alzheimer’s

Our survey of the patents recently issued by the USPTO to Merck showed us a great deal of innovation in the field of metabolic disorders and conditions, …
By Steve Brachmann
6 years ago 0

Pfizer Focuses Recent Patent Activity on Antibacterial Agents

Patent applications recently published by the U.S. Patent and Trademark Office show that Pfizer’s recent development goals have focused on a broad spectrum of diseases …
By Steve Brachmann
6 years ago 0

Patent Granted on Long-Acting Drug for Multiple Sclerosis

The conjugates covered by this patent could enable less frequent and better tolerated dosing of one of the most widely used treatments worldwide for relapsing-remitting multiple sclerosis, …
By Gene Quinn
8 years ago 0